Trevena CEO to present at the Jefferies 2015 Global Healthcare Conference
Business Wire - Thu Nov 12, 6:00AM CST
Trevena, Inc. (NASDAQ: TRVN), a clinical stage biopharmaceutical company focused on the discovery and development of biased ligands targeting G protein coupled receptors, today announced Maxine Gowen, Ph.D., its chief executive officer, will present a company overview at the Jefferies 2015 Global Healthcare Conference on Thursday November 19, 2015 at 3:20 p.m. GMT (10:20 a.m. EST) in London.
TRVN: 11.18 (+0.67)
Neither Bears Nor Bulls Can Rejoice
at The Street - Tue Nov 10, 3:20PM CST
The bears had a good opportunity early on but did nothing with it, though buyers gained little traction.
TRVN: 11.18 (+0.67), TWM: 39.12 (+0.56)
Big Picture Losing Focus
at The Street - Tue Nov 10, 9:30AM CST
Poor macro conditions but OK technical patterns.
TRVN: 11.18 (+0.67), TWM: 39.12 (+0.56)
Trevena reports 3Q loss
Automated Insights - Tue Nov 10, 6:33AM CST
KING OF PRUSSIA, Pa. (AP) _ Trevena Inc. (TRVN) on Tuesday reported a loss of $10.6 million in its third quarter.
TRVN: 11.18 (+0.67)
Trevena Reports Third Quarter 2015 Financial Results and Provides Corporate Update
Business Wire - Tue Nov 10, 6:00AM CST
--- TRV027 AHF Phase 2b trial on track to report top-line data in the second quarter of 2016 -
TRVN: 11.18 (+0.67)
The Bulls Have No Place to Hide
at The Street - Mon Nov 09, 3:37PM CST
The bears are locked and loaded.
NFLX: 103.65 (-5.27), TRVN: 11.18 (+0.67), TWM: 39.12 (+0.56), TSLA: 207.19 (-5.75), AMZN: 642.35 (-23.25), FB: 103.95 (-4.07), TREE: 116.49 (-2.51), GOOGL: 740.07 (-16.46), MITK: 4.08 (+0.13), MSFT: 52.84 (-0.48)
The Bears Gain Momentum
at The Street - Mon Nov 09, 12:48PM CST
We'll see if there is any dip-buying interest as the day winds down.
NFLX: 103.65 (-5.27), TRVN: 11.18 (+0.67), TWM: 39.12 (+0.56), TSLA: 207.19 (-5.75), AMZN: 642.35 (-23.25), FB: 103.95 (-4.07), TREE: 116.49 (-2.51), GOOGL: 740.07 (-16.46), MITK: 4.08 (+0.13), MSFT: 52.84 (-0.48)
A Gloomy Market Morning
at The Street - Mon Nov 09, 9:48AM CST
There's been steady selling pressure all morning.
NFLX: 103.65 (-5.27), TRVN: 11.18 (+0.67), TWM: 39.12 (+0.56), TSLA: 207.19 (-5.75), AMZN: 642.35 (-23.25), FB: 103.95 (-4.07), TREE: 116.49 (-2.51), GOOGL: 740.07 (-16.46), MITK: 4.08 (+0.13), MSFT: 52.84 (-0.48)
Is a Surprise Coming for Trevena (TRVN) This Earnings Season?
Zacks Equity Research - Zacks Investment Research - Mon Nov 09, 7:46AM CST
Investors are always looking for stocks that are poised to beat at earnings season and Trevena (TRVN) may be one such company.
TRVN: 11.18 (+0.67)
Is Henry Schein (HSIC) Poised to Beat Earnings in Q3?
Zacks Equity Research - Zacks Investment Research - Tue Nov 03, 1:25PM CST
Henry Schein???s (HSIC) earnings have outpaced the Zacks Consensus Estimate in three of the past four quarters, with an average beat of 1.43%.
TRVN: 11.18 (+0.67), CLCD: 4.74 (+0.03), ITCI: 48.71 (+0.11), HSIC: 151.07 (-1.76)
Recent Technical Updates on HealthCare Stocks- Research on Edge Therapeutics, Castlight Health, Trevena and Omeros
ACCESSWIRE - Tue Nov 03, 7:35AM CST
NEW YORK, NY / ACCESSWIRE / November 03, 2015 / Moments ago, Trader's Choice released new research updates concerning several important developing situations including the following equities: Edge Therapeutics, Inc (NASDAQ: EDGE), Castlight Health Inc (NYSE: CSLT), Trevena Inc (NASDAQ: TRVN) and Omeros Corp (NASDAQ: OMER). Trader's Choice has perfected the profitable art of picking stocks, cutting through the noise to deliver the top trade, every year. The full research reports are being made available to the public on a complimentary basis.
TRVN: 11.18 (+0.67), CSLT: 3.85 (-0.02), EDGE: 15.06 (-0.71), OMER: 13.86 (+0.09)
Is Myriad Genetics (MYGN) Poised to Beat on Q1 Earnings?
Zacks Equity Research - Zacks Investment Research - Mon Nov 02, 1:45PM CST
The combination of Myriad's (MYGN) Zacks Rank #2 and +2.86% ESP makes us confident of a positive earnings beat at the company.
AMSG: 82.16 (+1.39), TRVN: 11.18 (+0.67), MYGN: 42.63 (-0.24), ZLTQ: 32.80 (+0.73)
Trevena Hosts Investor and Analyst Day
Business Wire - Wed Oct 28, 3:01PM CDT
--- Announces USAN-approved generic name for TRV130: oliceridine -
TRVN: 11.18 (+0.67)
Trevena, Inc. (Nasdaq: TRVN) to Ring The Nasdaq Stock Market Closing Bell
GlobeNewswire - Tue Oct 27, 9:00AM CDT
What:
TRVN: 11.18 (+0.67), NDAQ: 56.59 (-1.12)
5 Stocks Poised for Breakouts
at The Street - Fri Oct 23, 6:52AM CDT
These stocks are poised to break out and trade higher from current levels.
AGEN: 4.63 (+0.11), TRVN: 11.18 (+0.67), VIPS: 13.60 (-5.02), MDLY: 5.66 (-0.13), STKL: 6.68 (+0.43)
Trevena to Host Analyst and Investor Day on October 28, 2015
Business Wire - Wed Oct 21, 6:00AM CDT
Trevena, Inc. (NASDAQ: TRVN), a clinical stage pharmaceutical company focused on the discovery and development of biased ligands targeting G protein coupled receptors (GPCRs), today announced that it will host an Analyst and Investor Day on Wednesday, October 28, 2015 in New York City. Presentations will begin at 12:00 p.m. Eastern Daylight Time and will be streamed simultaneously as a webcast. The event is expected to conclude by 3:00 p.m.
TRVN: 11.18 (+0.67)
Bulls Steadfast, but Market Players Skittish
at The Street - Mon Oct 19, 3:07PM CDT
Not a big day of gains, but there is underlying support.
NFLX: 103.65 (-5.27), AMZN: 642.35 (-23.25), TRVN: 11.18 (+0.67), ESPR: 26.61 (+0.01), FB: 103.95 (-4.07), GOOGL: 740.07 (-16.46), MXL: 16.08 (-0.20), AAPL: 112.34 (-3.38)
Market Dives With Bluebird
at The Street - Mon Oct 19, 12:59PM CDT
This sort of action is a symptom of a market with limited confidence.
TRVN: 11.18 (+0.67), ESPR: 26.61 (+0.01), FB: 103.95 (-4.07), MXL: 16.08 (-0.20)
A Classic Example of Reflexive Buying
at The Street - Mon Oct 19, 9:26AM CDT
There are good reasons to correct, but the bulls are holding up.
TRVN: 11.18 (+0.67), ESPR: 26.61 (+0.01), FB: 103.95 (-4.07), MXL: 16.08 (-0.20)
Say What You Will, Bears: Price Action Is Good
at The Street - Fri Oct 16, 3:11PM CDT
Intraday dip buying is a good sign.
NFLX: 103.65 (-5.27), TRVN: 11.18 (+0.67), GE: 30.28 (+0.12), MXL: 16.08 (-0.20)